| Treatment | ROM | 95% CI lower limit | 95% CI upper limit | z | P |
| Dobutamine | 1.0706 | 0.5674 | 2.0204 | 0.21 | 0.8331 |
| Levosimendan | 1.1444 | 0.7553 | 1.7341 | 0.64 | 0.5246 |
| Levosimendan + Dobutamine | 1.2253 | 0.4726 | 3.1765 | 0.42 | 0.6759 |
| Levosimendan + Milrinone + Dopamine | NA | NA | NA | NA | NA |
| Milrinone | 1.3098 | 0.8222 | 2.0867 | 1.14 | 0.2560 |
| Milrinone + Dobutamine | 1.4023 | 0.5241 | 3.7525 | 0.67 | 0.5007 |
| Milrinone + Dopamine | NA | NA | NA | NA | NA |
| Placebo | 1 | 1 | 1 | NA | NA |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.